Fiduciary Group LLC Sells 423 Shares of Kimberly-Clark Co. (NYSE:KMB)

Fiduciary Group LLC lowered its holdings in Kimberly-Clark Co. (NYSE:KMB) by 14.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,514 shares of the company’s stock after selling 423 shares during the period. Fiduciary Group LLC’s holdings in Kimberly-Clark were worth $305,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Emerald Advisors LLC lifted its stake in shares of Kimberly-Clark by 4.7% in the fourth quarter. Emerald Advisors LLC now owns 2,016 shares of the company’s stock valued at $245,000 after buying an additional 90 shares during the period. Aaron Wealth Advisors LLC raised its stake in shares of Kimberly-Clark by 1.5% in the fourth quarter. Aaron Wealth Advisors LLC now owns 6,418 shares of the company’s stock valued at $780,000 after purchasing an additional 93 shares in the last quarter. Motco lifted its position in Kimberly-Clark by 6.9% in the third quarter. Motco now owns 1,463 shares of the company’s stock worth $177,000 after purchasing an additional 94 shares during the period. S&CO Inc. boosted its stake in Kimberly-Clark by 0.4% during the third quarter. S&CO Inc. now owns 24,914 shares of the company’s stock worth $3,010,000 after buying an additional 100 shares in the last quarter. Finally, Journey Advisory Group LLC increased its holdings in Kimberly-Clark by 4.3% in the 3rd quarter. Journey Advisory Group LLC now owns 2,436 shares of the company’s stock valued at $294,000 after buying an additional 100 shares during the period. 76.29% of the stock is currently owned by institutional investors and hedge funds.

Kimberly-Clark Stock Up 0.5 %

Shares of NYSE:KMB opened at $135.93 on Tuesday. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05. The firm has a market cap of $45.77 billion, a P/E ratio of 24.99, a P/E/G ratio of 3.85 and a beta of 0.40. Kimberly-Clark Co. has a 12 month low of $116.32 and a 12 month high of $147.02. The company’s 50-day moving average price is $126.22 and its two-hundred day moving average price is $123.03.

Kimberly-Clark (NYSE:KMB) last issued its quarterly earnings results on Tuesday, April 23rd. The company reported $2.01 earnings per share for the quarter, beating analysts’ consensus estimates of $1.61 by $0.40. The business had revenue of $5.15 billion during the quarter, compared to analyst estimates of $5.08 billion. Kimberly-Clark had a net margin of 9.05% and a return on equity of 250.28%. Kimberly-Clark’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter last year, the business posted $1.67 earnings per share. As a group, research analysts forecast that Kimberly-Clark Co. will post 7 EPS for the current fiscal year.

Insider Transactions at Kimberly-Clark

In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 6,390 shares of the company’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $135.59, for a total transaction of $866,420.10. Following the transaction, the insider now directly owns 33,649 shares in the company, valued at approximately $4,562,467.91. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Paula Ramos sold 10,178 shares of the company’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total value of $1,396,116.26. Following the completion of the sale, the insider now owns 795 shares in the company, valued at $109,050.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey P. Melucci sold 6,390 shares of the stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $135.59, for a total value of $866,420.10. Following the completion of the transaction, the insider now directly owns 33,649 shares in the company, valued at approximately $4,562,467.91. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Citigroup raised their price objective on shares of Kimberly-Clark from $111.00 to $125.00 and gave the stock a “sell” rating in a report on Wednesday, April 24th. Bank of America lifted their price objective on Kimberly-Clark from $110.00 to $115.00 and gave the company an “underperform” rating in a report on Wednesday, April 24th. UBS Group increased their target price on Kimberly-Clark from $135.00 to $138.00 and gave the stock a “neutral” rating in a report on Wednesday, April 24th. Deutsche Bank Aktiengesellschaft boosted their price target on Kimberly-Clark from $127.00 to $132.00 and gave the company a “hold” rating in a research note on Thursday, March 28th. Finally, StockNews.com raised Kimberly-Clark from a “hold” rating to a “buy” rating in a report on Thursday, April 11th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $134.85.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.